Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
 

 

Pacific Northwest Node


The Pacific Northwest Node includes the Alcohol and Drug Abuse Institute at the University of Washington, and nine community treatment programs distributed geographically over Washington State and Alaska. These programs provide a mix of settings including: urban and rural, private and public sector, in-patient/residential and outpatient, and drug free and methadone maintenance programs. The CTPs provide a wide range of treatment services to nearly 12,000 clients per year. All available services are also targeted to specific groups having special needs such as women, the elderly, dual disorder clients, homeless populations, and adolescent clients.

 

Regional Research and Training Center

University of Washington
Alcohol and Drug Abuse Institute
1107 N.E. 45th Street
Suite 120
Seattle, WA 98105


Principal Investigator

Dennis M. Donovan, Ph. D.
Director
Alcohol and Drug Abuse Institute
Professor
Department of Psychiatry and Behavioral Sciences
University of Washington
1107 N.E. 45th Street, Suite 120
Box 354805
Seattle, WA 98105
206-543-0937
ddonovan@u.washington.edu


Community Treatment Programs

Evergreen Manor, Inc.
Everett, WA

Evergreen Treatment Services
Seattle, WA

Kitsap Recovery Center
Bremerton, WA

Providence Behavioral Health Service
Everett, WA

Recovery Centers of King County
Seattle, WA

Residence XII
Kirkland, WA

Southeast Alaska Regional Health Consortium
Sitka, AK

Triumph Treatment Services
Yakima, WA

Vancouver Division of Portland VAMC - Opiate Treatment Program
Portland, OR


Pacific Northwest Protocol Involvement
PROTOCOL0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
PROTOCOL0008 A Baseline for Investigating Diffusion of Innovation
PROTOCOL0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
PROTOCOL0015 Women's Treatment for Trauma and Substance Use Disorders
PROTOCOL0017 HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings
PROTOCOL0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
PROTOCOL0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
PROTOCOL0027 Starting Treatment with Agonist Replacement Therapies - START
PROTOCOL0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12)



 

 



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Thursday, June 26, 2008. The U.S. government's official web portal